⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
HIND News
Vyome Holdings, Inc. Common Stock
Vyome Announces the Publication of Positive Preclinical Results in Uveitis, Addressing a $3B Potential Market Opportunity
businesswire.com
HIND
Vyome Announces the Publication of Positive Preclinical Results in Uveitis, Addressing a $3B Potential Market Opportunity
businesswire.com
HIND
Vyome Successfully Capitalizes All VT-1953 Funding Requirements For Initial Phase 3 Results
businesswire.com
HIND
Independent Analyst Values Vyome’s VT-1953 at USD 1 Billion Upon Successful Completion of Phase 3 Study
businesswire.com
HIND
Vyome Appoints Renowned Medical Oncologist, Dr. Aditya Bardia, as Senior Medical Advisor to Guide the Development of MFW Program
businesswire.com
HIND
Vyome Holdings Announces Transformational First Quarter Following Nasdaq Listing
businesswire.com
HIND
Vyome Holdings Announces Results of Annual Shareholder Meeting
businesswire.com
HIND
Vyome Presents Strong Data Showing Topical VT-1908 is an Effective Treatment for Uveitis, Opening Up a $3B Addressable Market Opportunity
businesswire.com
HIND
Vyome Holdings Strengthens Leadership Team with Industry Veterans as it plans Pivotal Trial Studies
businesswire.com
HIND